Selected research
Market Analysis & Forecast
Global On-Site Coronavirus Testing Service Market Analysis and Forecast 2026-2032
Market perspective
The global On-Site Coronavirus Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for On-Site Coronavirus Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for On-Site Coronavirus Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for On-Site Coronavirus Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for On-Site Coronavirus Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of On-Site Coronavirus Testing Service include AB Medical Services (UK) Limited, Total Testing Solutions, CVS Health, CareCube, We Are Lifeline Health, EventScan, Fern Health Check, Live Better Solutions and BeCore, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for On-Site Coronavirus Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of On-Site Coronavirus Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for On-Site Coronavirus Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the On-Site Coronavirus Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global On-Site Coronavirus Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for On-Site Coronavirus Testing Service revenue, projected growth trends, production technology, application and end-user industry.
On-Site Coronavirus Testing Service Segment by Company
AB Medical Services (UK) Limited
Total Testing Solutions
CVS Health
CareCube
We Are Lifeline Health
EventScan
Fern Health Check
Live Better Solutions
BeCore
Alliance Nationwide Exposition
Covid Clinic
GENETWORx
Collinson Group
Prenetics
On-Site Coronavirus Testing Service Segment by Type
Throat Swab Testing
Nasal Swab Testing
Saliva Testing
On-Site Coronavirus Testing Service Segment by Application
Workplace
Large Event Site
Tourist Attraction
Other
On-Site Coronavirus Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global On-Site Coronavirus Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of On-Site Coronavirus Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of On-Site Coronavirus Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of On-Site Coronavirus Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of On-Site Coronavirus Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, On-Site Coronavirus Testing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Throat Swab Testing
- Nasal Swab Testing
- Saliva Testing
Applications
- Workplace
- Large Event Site
- Tourist Attraction
- Other
Companies covered
- AB Medical Services (UK) Limited
- Total Testing Solutions
- CVS Health
- CareCube
- We Are Lifeline Health
- EventScan
- Fern Health Check
- Live Better Solutions
- BeCore
- Alliance Nationwide Exposition
- Covid Clinic
- GENETWORx
- Collinson Group
- Prenetics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 On-Site Coronavirus Testing Service Market by Type
- 1.2.1 Global On-Site Coronavirus Testing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Throat Swab Testing
- 1.2.3 Nasal Swab Testing
- 1.2.4 Saliva Testing
- 1.3 On-Site Coronavirus Testing Service Market by Application
- 1.3.1 Global On-Site Coronavirus Testing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Workplace
- 1.3.3 Large Event Site
- 1.3.4 Tourist Attraction
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 On-Site Coronavirus Testing Service Market Dynamics
- 2.1 On-Site Coronavirus Testing Service Industry Trends
- 2.2 On-Site Coronavirus Testing Service Industry Drivers
- 2.3 On-Site Coronavirus Testing Service Industry Opportunities and Challenges
- 2.4 On-Site Coronavirus Testing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global On-Site Coronavirus Testing Service Market Perspective (2021-2032)
- 3.2 Global On-Site Coronavirus Testing Service Growth Trends by Region
- 3.2.1 Global On-Site Coronavirus Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global On-Site Coronavirus Testing Service Market Size by Region (2021-2026)
- 3.2.3 Global On-Site Coronavirus Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global On-Site Coronavirus Testing Service Revenue by Players
- 4.1.1 Global On-Site Coronavirus Testing Service Revenue by Players (2021-2026)
- 4.1.2 Global On-Site Coronavirus Testing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global On-Site Coronavirus Testing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global On-Site Coronavirus Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global On-Site Coronavirus Testing Service Key Players Headquarters & Area Served
- 4.4 Global On-Site Coronavirus Testing Service Players, Product Type & Application
- 4.5 Global On-Site Coronavirus Testing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global On-Site Coronavirus Testing Service Market CR5 and HHI
- 4.6.3 2025 On-Site Coronavirus Testing Service Tier 1, Tier 2, and Tier 3
5 On-Site Coronavirus Testing Service Market Size by Type
- 5.1 Global On-Site Coronavirus Testing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 5.3 Global On-Site Coronavirus Testing Service Revenue Market Share by Type (2021-2032)
6 On-Site Coronavirus Testing Service Market Size by Application
- 6.1 Global On-Site Coronavirus Testing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 6.3 Global On-Site Coronavirus Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 AB Medical Services (UK) Limited
- 7.1.1 AB Medical Services (UK) Limited Company Information
- 7.1.2 AB Medical Services (UK) Limited Business Overview
- 7.1.3 AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 AB Medical Services (UK) Limited On-Site Coronavirus Testing Service Product Portfolio
- 7.1.5 AB Medical Services (UK) Limited Recent Developments
- 7.2 Total Testing Solutions
- 7.2.1 Total Testing Solutions Company Information
- 7.2.2 Total Testing Solutions Business Overview
- 7.2.3 Total Testing Solutions On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Total Testing Solutions On-Site Coronavirus Testing Service Product Portfolio
- 7.2.5 Total Testing Solutions Recent Developments
- 7.3 CVS Health
- 7.3.1 CVS Health Company Information
- 7.3.2 CVS Health Business Overview
- 7.3.3 CVS Health On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 CVS Health On-Site Coronavirus Testing Service Product Portfolio
- 7.3.5 CVS Health Recent Developments
- 7.4 CareCube
- 7.4.1 CareCube Company Information
- 7.4.2 CareCube Business Overview
- 7.4.3 CareCube On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 CareCube On-Site Coronavirus Testing Service Product Portfolio
- 7.4.5 CareCube Recent Developments
- 7.5 We Are Lifeline Health
- 7.5.1 We Are Lifeline Health Company Information
- 7.5.2 We Are Lifeline Health Business Overview
- 7.5.3 We Are Lifeline Health On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 We Are Lifeline Health On-Site Coronavirus Testing Service Product Portfolio
- 7.5.5 We Are Lifeline Health Recent Developments
- 7.6 EventScan
- 7.6.1 EventScan Company Information
- 7.6.2 EventScan Business Overview
- 7.6.3 EventScan On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 EventScan On-Site Coronavirus Testing Service Product Portfolio
- 7.6.5 EventScan Recent Developments
- 7.7 Fern Health Check
- 7.7.1 Fern Health Check Company Information
- 7.7.2 Fern Health Check Business Overview
- 7.7.3 Fern Health Check On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Fern Health Check On-Site Coronavirus Testing Service Product Portfolio
- 7.7.5 Fern Health Check Recent Developments
- 7.8 Live Better Solutions
- 7.8.1 Live Better Solutions Company Information
- 7.8.2 Live Better Solutions Business Overview
- 7.8.3 Live Better Solutions On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Live Better Solutions On-Site Coronavirus Testing Service Product Portfolio
- 7.8.5 Live Better Solutions Recent Developments
- 7.9 BeCore
- 7.9.1 BeCore Company Information
- 7.9.2 BeCore Business Overview
- 7.9.3 BeCore On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 BeCore On-Site Coronavirus Testing Service Product Portfolio
- 7.9.5 BeCore Recent Developments
- 7.10 Alliance Nationwide Exposition
- 7.10.1 Alliance Nationwide Exposition Company Information
- 7.10.2 Alliance Nationwide Exposition Business Overview
- 7.10.3 Alliance Nationwide Exposition On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Alliance Nationwide Exposition On-Site Coronavirus Testing Service Product Portfolio
- 7.10.5 Alliance Nationwide Exposition Recent Developments
- 7.11 Covid Clinic
- 7.11.1 Covid Clinic Company Information
- 7.11.2 Covid Clinic Business Overview
- 7.11.3 Covid Clinic On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Covid Clinic On-Site Coronavirus Testing Service Product Portfolio
- 7.11.5 Covid Clinic Recent Developments
- 7.12 GENETWORx
- 7.12.1 GENETWORx Company Information
- 7.12.2 GENETWORx Business Overview
- 7.12.3 GENETWORx On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 GENETWORx On-Site Coronavirus Testing Service Product Portfolio
- 7.12.5 GENETWORx Recent Developments
- 7.13 Collinson Group
- 7.13.1 Collinson Group Company Information
- 7.13.2 Collinson Group Business Overview
- 7.13.3 Collinson Group On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Collinson Group On-Site Coronavirus Testing Service Product Portfolio
- 7.13.5 Collinson Group Recent Developments
- 7.14 Prenetics
- 7.14.1 Prenetics Company Information
- 7.14.2 Prenetics Business Overview
- 7.14.3 Prenetics On-Site Coronavirus Testing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Prenetics On-Site Coronavirus Testing Service Product Portfolio
- 7.14.5 Prenetics Recent Developments
8 North America
- 8.1 North America On-Site Coronavirus Testing Service Revenue (2021-2032)
- 8.2 North America On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 8.2.1 North America On-Site Coronavirus Testing Service Revenue by Type (2021-2026)
- 8.2.2 North America On-Site Coronavirus Testing Service Revenue by Type (2027-2032)
- 8.3 North America On-Site Coronavirus Testing Service Revenue Share by Type (2021-2032)
- 8.4 North America On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 8.4.1 North America On-Site Coronavirus Testing Service Revenue by Application (2021-2026)
- 8.4.2 North America On-Site Coronavirus Testing Service Revenue by Application (2027-2032)
- 8.5 North America On-Site Coronavirus Testing Service Revenue Share by Application (2021-2032)
- 8.6 North America On-Site Coronavirus Testing Service Revenue by Country
- 8.6.1 North America On-Site Coronavirus Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America On-Site Coronavirus Testing Service Revenue by Country (2021-2026)
- 8.6.3 North America On-Site Coronavirus Testing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe On-Site Coronavirus Testing Service Revenue (2021-2032)
- 9.2 Europe On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 9.2.1 Europe On-Site Coronavirus Testing Service Revenue by Type (2021-2026)
- 9.2.2 Europe On-Site Coronavirus Testing Service Revenue by Type (2027-2032)
- 9.3 Europe On-Site Coronavirus Testing Service Revenue Share by Type (2021-2032)
- 9.4 Europe On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 9.4.1 Europe On-Site Coronavirus Testing Service Revenue by Application (2021-2026)
- 9.4.2 Europe On-Site Coronavirus Testing Service Revenue by Application (2027-2032)
- 9.5 Europe On-Site Coronavirus Testing Service Revenue Share by Application (2021-2032)
- 9.6 Europe On-Site Coronavirus Testing Service Revenue by Country
- 9.6.1 Europe On-Site Coronavirus Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe On-Site Coronavirus Testing Service Revenue by Country (2021-2026)
- 9.6.3 Europe On-Site Coronavirus Testing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China On-Site Coronavirus Testing Service Revenue (2021-2032)
- 10.2 China On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 10.2.1 China On-Site Coronavirus Testing Service Revenue by Type (2021-2026)
- 10.2.2 China On-Site Coronavirus Testing Service Revenue by Type (2027-2032)
- 10.3 China On-Site Coronavirus Testing Service Revenue Share by Type (2021-2032)
- 10.4 China On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 10.4.1 China On-Site Coronavirus Testing Service Revenue by Application (2021-2026)
- 10.4.2 China On-Site Coronavirus Testing Service Revenue by Application (2027-2032)
- 10.5 China On-Site Coronavirus Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia On-Site Coronavirus Testing Service Revenue (2021-2032)
- 11.2 Asia On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 11.2.1 Asia On-Site Coronavirus Testing Service Revenue by Type (2021-2026)
- 11.2.2 Asia On-Site Coronavirus Testing Service Revenue by Type (2027-2032)
- 11.3 Asia On-Site Coronavirus Testing Service Revenue Share by Type (2021-2032)
- 11.4 Asia On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 11.4.1 Asia On-Site Coronavirus Testing Service Revenue by Application (2021-2026)
- 11.4.2 Asia On-Site Coronavirus Testing Service Revenue by Application (2027-2032)
- 11.5 Asia On-Site Coronavirus Testing Service Revenue Share by Application (2021-2032)
- 11.6 Asia On-Site Coronavirus Testing Service Revenue by Country
- 11.6.1 Asia On-Site Coronavirus Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia On-Site Coronavirus Testing Service Revenue by Country (2021-2026)
- 11.6.3 Asia On-Site Coronavirus Testing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA On-Site Coronavirus Testing Service Revenue (2021-2032)
- 12.2 SAMEA On-Site Coronavirus Testing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA On-Site Coronavirus Testing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA On-Site Coronavirus Testing Service Revenue by Type (2027-2032)
- 12.3 SAMEA On-Site Coronavirus Testing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA On-Site Coronavirus Testing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA On-Site Coronavirus Testing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA On-Site Coronavirus Testing Service Revenue by Application (2027-2032)
- 12.5 SAMEA On-Site Coronavirus Testing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA On-Site Coronavirus Testing Service Revenue by Country
- 12.6.1 SAMEA On-Site Coronavirus Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA On-Site Coronavirus Testing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA On-Site Coronavirus Testing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst